Put This Stock On Watch
Fast growing company in fast-growing wellness market starting to draw attention.
Read more here

IMPL Insider Trading (Impel NeuroPharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $8,625,000.00
Insider Selling (Last 12 Months): $0.00

Impel NeuroPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Impel NeuroPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Impel NeuroPharma Share Price & Price History

Current Price: $7.35
Price Change: +0.30 (1.20%)
As of 06/24/2021 04:59 PM ET

This chart shows the closing price history over time for IMPL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Put This Stock On Watch
Fast growing company in fast-growing wellness market starting to draw attention.
Read more here

Impel NeuroPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/27/2021Vivo Capital Viii, LlcMajor ShareholderBuy575,000$15.00$8,625,000.0098,927View SEC Filing Icon  
See Full Table
Insider Selling at Impel NeuroPharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Impel NeuroPharma and related companies.

SEC Filings (Institutional Ownership Changes) for Impel NeuroPharma (NASDAQ:IMPL)

Impel NeuroPharma logo
Impel NeuroPharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa for the treatment of OFF episodes in Parkinson's disease. Impel NeuroPharma, Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.
Read More on Impel NeuroPharma

Today's Range

Now: $7.35
Low: $6.96
High: $7.63

50 Day Range

MA: N/A

52 Week Range

Now: $7.35
Low: $7.35
High: $15.89

Volume

8,476 shs

Average Volume

77,796 shs

Market Capitalization

$163.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Impel NeuroPharma?

Impel NeuroPharma's top insider shareholders include:
  1. Vivo Capital Viii, Llc (Major Shareholder)
Put This Stock On Watch
Fast growing company in fast-growing wellness market starting to draw attention.
Read more here